ClinicalTrials HQ

Evaluation of Rifaximin SSD for Delaying Encephalopathy Decompensation in Patients With Cirrhosis

Evaluation of Rifaximin SSD for Delaying Encephalopathy Decompensation in Patients With Cirrhosis

Active, not recruiting · NCT05297448 · Registry updated 2025-09-10
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Evaluation of Rifaximin SSD for Delaying Encephalopathy Decompensation in Patients With CirrhosisBrain Diseases, Metabolic, Digestive System Diseases, Hepatic Insufficiency, Nutritional and Metabolic Diseases, brain disorder, central nervous system disorder, hepatic encephalopathy, liver disorder, liver failure, metabolic disease, nervous system disorderActive, not recruitingPhase 32025-09-10NCT05297448

1 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Bausch Health Americas, Inc.23

188 results · Page 1 of 8

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Bausch Site 350MangaluruIndia1
Bausch Site 351SūratIndia1
Bausch Site 352BelagaviIndia1
Bausch Site 354NashikIndia1
Bausch Site 356NagpurIndia1
Bausch Site 361SecunderabadIndia1
Bausch Site 400HarrisburgUnited States1
Bausch Site 401The BronxUnited States1
Bausch Site 402BurlingtonUnited States1
Bausch Site 403SpringboroUnited States1
Bausch Site 404RoanokeUnited States1
Bausch Site 405OrangeUnited States1
Bausch Site 406DallasUnited States1
Bausch Site 407Port OrangeUnited States1
Bausch Site 409WacoUnited States1
Bausch Site 410DaytonUnited States1
Bausch Site 411SpartaUnited States1
Bausch Site 413New OrleansUnited States1
Bausch Site 414Los AngelesUnited States1
Bausch Site 415CoronadoUnited States1
Bausch Site 416Wichita FallsUnited States1
Bausch Site 418HialeahUnited States1
Bausch Site 421Orange CityUnited States1
Bausch Site 422SmithfieldUnited States1
Bausch Site 423ChattanoogaUnited States1